{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:34:22Z","timestamp":1760189662385,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["Grant KBN No 4 PO5A 049 17"],"award-info":[{"award-number":["Grant KBN No 4 PO5A 049 17"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01559","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T06:57:59Z","timestamp":1547794679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency \u2013 Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens"],"prefix":"10.3389","volume":"9","author":[{"given":"Przemyslaw","family":"Zdziarski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/thx.2004.029819","article-title":"Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins.","volume":"61","author":"Arish","year":"2007","journal-title":"Thorax"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2487","article-title":"CD4 cell count, and CD4\/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patients.","volume":"4","author":"Besada","year":"2016","journal-title":"PeerJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","article-title":"Interstitial Pneumonitis related to Rituximab therapy.","volume":"348","author":"Burton","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes.","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-012-9755-9753","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).","volume":"33","author":"Chase","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3892\/etm.2015.2264","article-title":"Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK\/ERK signaling pathways.","volume":"9","author":"Deng","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/01.rhu.0000262585.18582.1e","article-title":"Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia.","volume":"13","author":"Finger","year":"2007","journal-title":"J. Clin. Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","article-title":"Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.","volume":"66","author":"Garnelo","year":"2017","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4161\/mabs.26008","article-title":"Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics. mAbs","author":"Golay","year":"2013"},{"key":"B10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British Lung Foundation\/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.","volume":"5","author":"Hurst","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.05.00030805","article-title":"Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients.","volume":"26","author":"Katchar","year":"2005","journal-title":"Eur. Respir. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1378\/chest.07-0128","article-title":"Expansion of pulmonary CD8CD56 natural killer T-cells in hypersensitivity Pneumonitis. Chest","author":"Korosec","year":"2007"},{"key":"B14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ppul.21160","article-title":"Rituximab-induced pneumonitis: steroid therapy or not?","volume":"45","author":"Liot\u00e9","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry.","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075199","article-title":"IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.","volume":"8","author":"Paquin-Proulx","year":"2013","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1078-0432.CCR-16-0040","article-title":"CTLA-4 limits anti-CD20-mediated tumor regression.","volume":"23","author":"Ren","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1371.e2","DOI":"10.1016\/j.jaci.2011.07.055","article-title":"Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency.","volume":"128","author":"Rizzi","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/039463201002300207","article-title":"Decreased interstitial Foxp3+lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12\/CXCR4 axis.","volume":"23","author":"Shimizu","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31823ac199","article-title":"Dramatic reversal of lymphocytic interstitial pneumonitis in Sj\u00f6gren\u2019s syndrome with rituximab.","volume":"17","author":"Swartz","year":"2011","journal-title":"J. Clin. Rheumatol."},{"key":"B21","article-title":"Rituximab effective for lymphocytic interstitial pneumonitis associated with sjogren\u2019s syndrome: a case report: cgr013.","volume":"43","author":"Tansy","year":"2013","journal-title":"Int. Med. J."},{"key":"B22","first-page":"207","article-title":"Quantitative and functional evaluation of innate immune responses in patients with common variable immunodeficiency.","volume":"21","author":"Trujillo","year":"2011","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaip.2014.09.019","article-title":"Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.","volume":"3","author":"Vitale","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation in 25 patients with common variable immunodeficiency.","volume":"135","author":"Wehr","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/ajh.23272","article-title":"Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.","volume":"87","author":"Zaja","year":"2012","journal-title":"Am. J. Hematol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4172\/1745-7580.10000119","article-title":"Role of chemokine signalling in the pathogenesis of good\u2019s syndrome-case reports, clinical characterization from single-centre perspective.","volume":"12","author":"Zdziarski","year":"2016","journal-title":"Immunome Res."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007031","article-title":"A case report of lymphoid intestitial pneumonia in common variable immunodeficiency: oligoclonal expansion of effector lymphocytes with preferential cytomegalovirus-specific immune response and lymphoproliferative disease promotion.","volume":"96","author":"Zdziarski","year":"2017","journal-title":"Medicine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T06:58:01Z","timestamp":1547794681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":27,"alternative-id":["10.3389\/fphar.2018.01559"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01559","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"article-number":"1559"}}